Pfizer (PFE) executive says obesity study results increase significantly Co's confidence in Phase 3 monthly dosing study set to launch this year; targeting the first of a series of potential obesity approvals in 2028

Pfizer's announcement regarding increased confidence in their obesity study suggests a promising outlook for their Phase 3 trial, indicative of potential positive revenue streams in the future.

Newsquawk StaffPublished 3 Feb 2026, 12:10 UTCOn the live feed at 11:50 UTC — 10 more headlines followed before this page went public

Newsquawk headlinesUTC

11:55

AMETEK Inc. (AME) Q4 2025 (USD): Basic EPS 1.74 (exp. 1.94), Revenue 1.998bln (exp. 1.95bln)

11:53

US envoy Witkoff arrives in Israel

11:50

Pfizer (PFE) executive says obesity study results increase significantly Co's confidence in Phase 3 monthly dosing study set to launch this year; targeting the first of a series of potential obesity approvals in 2028

11:45

Pfizer Inc. (PFE) Q4 2025 (USD): Adj. EPS 0.66 (exp. 0.58), Revenue 17.6bln (exp. 16.85bln); FY26 revenue view 59.5-62.5bln (exp. 61.94bln), FY26 EPS 2.80-3.00 (exp. 2.97)

11:41

Ukraine's President Zelensky calls for additional support following discussion with NATO's Rutte

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Context

This could heavily influence investor sentiment, as the market often responds favorably to strong clinical trial news, especially when tied to large target markets like obesity management. Traders should monitor how this information impacts Pfizer's stock trajectory and the broader pharmaceutical sector, particularly as upcoming trials and approvals unfold.

Equities · last 90 days

Recent headlines that moved markets

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

Modest downside seen across equity futures as energy prices tick higher.

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

EQUITIES/26 Aug · 12:56 UTC

States and Meta (META) and agree to settle claims that platforms harmed children, according to a court filing; Meta agrees to pay a maximum of USD 16.68bln to states as part of deal

Market, after we published+2.6%

EQUITIES/7 Sept · 10:54 UTC

Saudi Aramco Jizan oil facilities were reportedly hit in new strikes, the FT reports citing sources; hit on Monday, damage is being assessed.

Equity indices, after we published−0.1%

EQUITIES/7 Sept · 09:15 UTC

Volkswagen (VOW3 GY) says that the Co., Lower Saxony and Aurelius Capital have agreed on key terms for the sale of Osnabrueck Plant; aims to secure the site and majority of jobs in the long term.

Market, after we published+1.6%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.